CD4 and central nervous system cancer: Of note, patients with malignant tumors of central nervous system (i.e. gliomas) are characterized by dramatic reductions in CD4+ T cell number and a disproportionate presence of immunosuppressive regulatory T cells [36], exactly the same features of our mice bearing NPC-derived tumors.